http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0401888-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2730b36127aaa67f769c57be64885dc
publicationDate 2006-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0401888-A
titleOfInvention Oral application form for 3 - [(2 - {[4- (hexyloxycarbonylamino-imino-methyl) -phenylamino] -methyl} -1-methyl-1h-benzimidazol-5-carbonyl) -pyridin-2-acid ethyl esters il-amino] -propionic and its salts
abstract "ORAL FORM OF APPLICATION FOR 3- ¢ (2- {¢ 4- (HEXYLOXICARBONYLAMINE-IMMINETHYL) (PHENYLAMINE O! -METHYL) -1-METHYL-BENZIMIDAZOL-5-CARBONYL ACID ETHYLTERS" L-AMINO! -PROPYNIC AND ITS SALTS ". The present invention relates to a novel oral application form to be applied to the 3- ¢ (2- {¢ 4- (hexyloxycarbonylamino-imino-methyl) -phenylaminolmethyl} -1-methyl-1 H acid ethylester active substance -benzimidazol-5-carbonyl) -pyridin-2-yl-amino-propionic and pharmaceutically compatible salts thereof.
priorityDate 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479687

Total number of triples: 13.